Knowledge and Attitude to HIV Pre Exposure Prophylaxis among Women in Five Sub-Saharan African Countries: A multilevel model analysis of population-based survey 2021–2022

14 May 2024

This article from BMC Public Health assesses women’s knowledge and attitudes towards PrEP in Burkina Faso, Côte d’Ivoire, Ghana, Kenya, and Tanzania.

Featured Resources

Document

Pre-Exposure Prophylaxis and Adolescent Girls and Young Women in Eastern and Southern Africa: The latest insights

Eastern and southern Africa (ESA) is the world’s most heavily HIV-impacted region, with adolescent girls and young women (AGYW) disproportionately affected. To support the scale-up of PrEP amongst AGYW in ESA, in September 2021 UNICEF and partners released the implementation brief “Improving the Quality of Pre-Exposure Prophylaxis Implementation for Adolescent Girls and Young Women in…

External Link

WHO Implementation Tool for Pre-Exposure Prophylaxis (PrEP) of HIV Infection

The WHO has developed this series of modules to support the implementation of PrEP among a range of populations in different settings.

External Link

Low Selection of HIV PrEP Refills at Private Pharmacies among Clients who Initiated PrEP at Public Clinics: Findings from a mixed-methods study in Kenya

This article from BMC Health Services Research describes the impact of a pilot project to permit oral PrEP users to obtain refills at private pharmacies for an additional fee.

Presentation

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Presentation

From October 2023 to April 2024, MOSAIC supported the Federal Ministry of Health to evaluate the National Oral PrEP Implementation Plan (Jan 2022 – Jan 2024). The purpose of the evaluation was to assess the achievement of priority activities stipulated in the National Oral PrEP Implementation Plan (Jan 2022-Jan 2024) against the intended objectives. The…

Document

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Report

External Link

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled analysis from 72 global studies

This article from Clinical Infectious Diseases reviews 72 prospective studies of daily oral PrEP (TDF/FTC) to evaluate its impact on HIV-1 incidence, drug resistance, adherence, and bone and renal safety in diverse settings.

Document

MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention)

Short introduction to MOSAIC, a project working across multiple countries to implement user-centered research and research translation efforts to identify, understand, and remove barriers to new product introduction, access, and use; coordinate and provide technical assistance to global, national, and subnational stakeholders to expedite product launch and scale-up; and strengthen the capacity of a wide…

Document

Access, Adherence, and Acute HIV Infections: A characterization of seroconversion with PrEP in Eswatini

This poster, presented at the INTEREST conference in Cotonou, Benin in 2024, outlines characteristics of seroconversions by women using oral PrEP or the dapivirine vaginal ring in Eswatini.

External Link

Youth-friendly Services Was the Magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa

This article from Global Public Health describes the results of a study to measure the impact of HIV prevention empowerment counselling on PrEP use by adolescent girls and young women in South Africa.

External Link

Discontinuation of HIV Oral Pre-exposure Prophylaxis: Findings from programmatic surveillance within two general population HIV programs in Nigeria

This article from BMC Public Health explores the factors associated with discontinuation of oral PrEP within one month of initiation in two large HIV projects in Nigeria.